Lydia Ogden leads R&D policy and engagement for Johnson & Johnson’s Global Public Health division. She is a proven public- and private-sector leader with three decades of experience in predicting and managing health system change and enabling impactful health partnerships spanning the globe.
Before joining J&J, Lydia directed U.S. and ex-U.S. vaccines policy, partnerships and government relations for Merck (MSD outside the U.S. and Canada) and led company-wide strategic engagement with international organizations, foundations, institutions and industry associations.
She also worked at the U.S. Centers for Disease Control and Prevention, where she led domestic and international HIV/AIDS policy and data-driven prevention programs, implemented PEPFAR (the U.S. President’s Emergency Plan for AIDS Relief), served as the agency’s deputy chief of staff for policy, and headed the Office of Health Reform following passage of the Affordable Care Act.
Lydia earned a Doctor of Philosophy in health services research and health policy from Emory University; a Master of Public Policy from the Harvard Kennedy School; a Master of Arts in English language and literature from Vanderbilt University; and a Bachelor of Science in English language and literature from Middle Tennessee State University.